Innate Pharma (IPHA) Short Interest Ratio & Short Volume $2.06 -0.04 (-1.90%) (As of 12/24/2024 04:20 PM ET) Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends Innate Pharma Short Interest DataInnate Pharma (IPHA) has a short interest of 63,000 shares. This marks a -1.10% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.3, indicating that it would take 0.3 days of the average trading volume of 127,472 shares to cover all short positions.Current Short Interest63,000 sharesPrevious Short Interest63,700 sharesChange Vs. Previous Month-1.10%Dollar Volume Sold Short$97,020.00Short Interest Ratio0.3 Days to CoverLast Record DateNovember 30, 2024Outstanding Shares82,802,000 sharesPercentage of Shares Shorted0.08%Today's Trading Volume24,122 sharesAverage Trading Volume127,472 sharesToday's Volume Vs. Average19% Short Selling Innate Pharma? Sign up to receive the latest short interest report for Innate Pharma and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartIPHA Short Interest Over TimeIPHA Days to Cover Over TimeIPHA Percentage of Float Shorted Over Time Ad Behind the MarketsWARNING: “Buffett Indicator” flashing for first time in 50 yearsWarren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indicates the Oracle of Omaha is quietly preparing for a historic market crash. His most reliable crash indicator - the "Buffett indicator" - just flashed red for the first time in 25 years.Take these 4 steps today to protect your retirement NOW Innate Pharma Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 11/30/202463,000 shares $97,020.00 -1.1%N/A0.3 $1.54 11/15/202463,700 shares $91,728.00 -2.3%N/A6.2 $1.44 10/31/202465,200 shares $123,293.20 +10.9%N/A7.8 $1.89 10/15/202458,800 shares $119,364.00 -18.1%N/A7.4 $2.03 9/30/202471,800 shares $164,422.00 +20.3%N/A10 $2.29 9/15/202459,700 shares $134,922.00 -8.3%N/A9 $2.26 Get the Latest News and Ratings for IPHA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Innate Pharma and its competitors with MarketBeat's FREE daily newsletter. 8/31/202465,100 shares $149,404.50 -2.5%N/A9.3 $2.30 8/15/202466,800 shares $150,300.00 +3.6%N/A8.1 $2.25 7/31/202464,500 shares $138,352.50 -11.5%N/A7.8 $2.15 7/15/202472,900 shares $154,548.00 +5.2%N/A9.1 $2.12 6/30/202469,300 shares $134,442.00 -4.9%N/A7.7 $1.94 6/15/202472,900 shares $171,315.00 +4.1%N/A7 $2.35 5/31/202470,000 shares $191,800.00 -0.3%N/A6.7 $2.74 5/15/202470,200 shares $175,942.26 -11.3%N/A7.2 $2.51 4/30/202479,100 shares $182,721.00 -2.7%N/A8.8 $2.31 4/15/202481,300 shares $196,746.00 +5.7%N/A7.8 $2.42 3/31/202476,900 shares $221,472.00 -13.7%N/A7.7 $2.88 3/15/202489,100 shares $217,404.00 +13.7%N/A7.6 $2.44 2/29/202478,400 shares $205,408.00 -4.9%N/A4.1 $2.62 2/15/202482,400 shares $212,592.00 +8.4%N/A4.7 $2.58 1/31/202476,000 shares $203,680.00 -0.9%N/A4 $2.68 1/15/202476,700 shares $214,760.00 -8.9%N/A3.7 $2.80 12/31/202384,200 shares $235,760.00 +55.9%N/A3.9 $2.80 12/15/202354,000 shares $130,140.00 -5.9%N/A2.6 $2.41 11/30/202357,400 shares $137,760.00 -4.3%N/A4.3 $2.40 11/15/202360,000 shares $147,600.00 -6.0%N/A4.2 $2.46 10/31/202363,800 shares $151,844.00 +11.5%N/A4.4 $2.38 10/15/202357,200 shares $132,418.00 -8.5%N/A5 $2.32 9/30/202362,500 shares $158,125.00 -3.4%N/A6 $2.53 9/15/202364,700 shares $192,159.00 -1.5%N/A6.7 $2.97 8/31/202365,700 shares $191,324.97 -8.1%N/A5.2 $2.91 8/15/202371,500 shares $206,635.00 -3.8%N/A6.1 $2.89 7/31/202374,300 shares $218,442.00 -1.9%N/A6.8 $2.94 7/15/202375,700 shares $244,511.00 -3.8%N/A6.4 $3.23 6/30/202378,700 shares $242,002.50 +20.0%N/A6.1 $3.08 6/15/202365,600 shares $213,856.00 +9.7%N/A4 $3.26 5/31/202359,800 shares $175,812.00 -4.3%N/A3.8 $2.94 5/15/202362,500 shares $186,875.00 No ChangeN/A3.6 $2.99 10/31/2022147,600 shares $317,340.00 +12.8%N/A12.9 $2.15 10/15/2022130,900 shares $261,800.00 +15.5%N/A12.5 $2.00$2 Trillion Disappears Because of Fed's Secretive New Move (Ad)$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being carried out by the Fed that has nothing to do with lowering or raising interest rates... but could soon have an enormous impact on your wealth.Click here to see his new research now. 9/30/2022113,300 shares $226,600.00 +1.3%N/A12.7 $2.00 9/15/2022111,900 shares $284,226.00 +2.3%N/A13.3 $2.54 8/31/2022109,400 shares $293,192.00 +0.2%N/A6.4 $2.68 8/15/2022109,200 shares $321,048.00 -10.1%N/A5.9 $2.94 7/31/2022121,500 shares $388,787.85 -3.6%N/A6.1 $3.20 7/15/2022126,000 shares $347,760.00 +0.3%N/A4.9 $2.76 6/30/2022125,600 shares $339,120.00 +3.9%N/A4.8 $2.70 6/15/2022120,900 shares $305,877.00 +1.9%N/A4.6 $2.53 5/31/2022118,700 shares $315,742.00 -13.6%N/A6.2 $2.66 5/15/2022137,300 shares $394,051.00 +8.0%N/A6.7 $2.87 4/30/2022127,100 shares $364,777.00 -9.3%N/A5.7 $2.87 4/15/2022140,100 shares $438,513.00 +4.0%N/A6 $3.13 3/31/2022134,700 shares $452,592.00 +105.0%N/A5.3 $3.36 3/15/202265,700 shares $207,612.00 +13.9%N/A1.6 $3.16 2/28/202257,700 shares $196,757.00 -2.5%N/A1 $3.41 2/15/202259,200 shares $219,632.00 -15.6%N/A0.9 $3.71 1/31/202270,100 shares $265,679.00 -15.3%N/A1 $3.79 1/15/202282,800 shares $375,084.00 -22.3%N/A1.1 $4.53 12/31/2021106,600 shares $486,096.00 +247.2%N/A1.3 $4.56 12/15/202130,700 shares $158,105.00 +0.3%N/A0.3 $5.15 11/30/202130,600 shares $151,776.00 -39.8%N/A0 $4.96 11/15/202150,800 shares $263,652.00 +195.4%N/A0 $5.19 10/29/202117,200 shares $99,760.00 +18.6%N/A0 $5.80 10/15/202114,500 shares $85,115.00 -89.5%N/A0 $5.87 9/30/2021137,800 shares $850,226.00 +79.7%N/A0.1 $6.17 9/15/202176,700 shares $427,986.00 +2,456.7%N/A0 $5.58 8/31/20213,000 shares $10,920.00 -45.5%N/A0 $3.64 8/13/20215,500 shares $18,700.00 -35.3%N/A0.3 $3.40 7/30/20218,500 shares $28,220.00 -33.6%N/A0.5 $3.32 7/15/202112,800 shares $41,472.00 +100.0%N/A0.7 $3.24 6/30/20216,400 shares $21,056.00 -61.0%N/A0.4 $3.29 6/15/202116,400 shares $65,764.00 +1,161.5%N/A1.1 $4.01 5/28/20211,300 shares $5,083.00 +225.0%N/A0.1 $3.91 5/14/2021400 shares $1,580.00 -81.8%N/A0 $3.95 4/30/20212,200 shares $9,416.00 -29.0%N/A0.1 $4.28 4/15/20213,100 shares $13,578.00 -55.7%N/A0 $4.38 3/31/20217,000 shares $30,030.00 -6.7%N/A0.2 $4.29 3/15/20217,500 shares $34,275.00 +53.1%N/A0.2 $4.57 2/26/20214,900 shares $21,658.00 -27.9%N/A0.1 $4.42 2/12/20216,800 shares $30,804.00 +385.7%N/A0.2 $4.53 1/29/20211,400 shares $5,740.00 -74.1%N/A0 $4.10 1/15/20215,400 shares $24,516.00 -77.2%N/A0.2 $4.54 12/31/202023,700 shares $102,147.00 -52.5%N/A0.9 $4.31 12/15/202049,900 shares $219,061.00 +91.2%N/A2.5 $4.39 11/30/202026,100 shares $145,116.00 -7.1%N/A1.5 $5.56 11/15/202028,100 shares $133,475.00 -23.2%N/A1.6 $4.75 10/30/202036,600 shares $146,217.00 +21.6%N/A2.5 $4.00 10/15/202030,100 shares $121,002.00 +32.6%N/A2.5 $4.02 9/30/202022,700 shares $87,168.00 -22.5%N/A2.2 $3.84 9/15/202029,300 shares $127,455.00 +70.4%N/A2.9 $4.35$2 Trillion Disappears Because of Fed's Secretive New Move (Ad)$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being carried out by the Fed that has nothing to do with lowering or raising interest rates... but could soon have an enormous impact on your wealth.Click here to see his new research now. 8/31/202017,200 shares $106,812.00 -5.5%N/A2.2 $6.21 8/14/202018,200 shares $119,210.00 -40.9%N/A2.3 $6.55 7/31/202030,800 shares $187,205.48 +76.0%N/A3.3 $6.08 7/15/202017,500 shares $105,175.00 +25.9%N/A2.1 $6.01 6/30/202013,900 shares $88,404.00 -0.7%N/A1.7 $6.36 6/15/202014,000 shares $87,780.00 -23.1%N/A1.4 $6.27 5/29/202018,200 shares $121,030.00 -59.4%N/A1.3 $6.65 5/15/202044,800 shares $300,160.00 +44.5%N/A2.7 $6.70 4/30/202031,000 shares $235,600.00 -13.9%N/A1.9 $7.60 4/15/202036,000 shares $251,100.00 -15.3%N/A2.3 $6.98 3/31/202042,500 shares $320,875.00 -29.9%N/A2.1 $7.55 3/13/202060,600 shares $390,870.00 -5.2%N/A6.5 $6.45 2/28/202063,900 shares $274,770.00 +47.2%N/A2.1 $4.30 2/14/202043,400 shares $298,592.00 +2.4%N/A1.3 $6.88 1/31/202042,400 shares $318,424.00 -1.6%N/A1.2 $7.51 1/15/202043,100 shares $322,388.00 +8.6%N/A1 $7.48 12/31/201939,700 shares $289,016.00 No ChangeN/A0.6 $7.28 IPHA Short Interest - Frequently Asked Questions What is Innate Pharma's current short interest? Short interest is the volume of Innate Pharma shares that have been sold short but have not yet been closed out or covered. As of November 30th, investors have sold 63,000 shares of IPHA short. Learn More on Innate Pharma's current short interest. Is Innate Pharma's short interest increasing or decreasing? Innate Pharma saw a decrease in short interest in the month of November. As of November 30th, there was short interest totaling 63,000 shares, a decrease of 1.1% from the previous total of 63,700 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Innate Pharma's short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Innate Pharma: CARGO Therapeutics, Inc. (17.64%), Rapport Therapeutics (10.25%), Entrada Therapeutics, Inc. (7.02%), Exscientia plc (2.55%), Stoke Therapeutics, Inc. (12.71%), Pharvaris (1.19%), Arbutus Biopharma Co. (3.07%), Humacyte, Inc. (19.60%), ORIC Pharmaceuticals, Inc. (16.00%), Autolus Therapeutics plc (2.36%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Co. ($5.70 billion), Charter Communications, Inc. ($4.55 billion), Spotify Technology S.A. ($3.84 billion), Royal Caribbean Cruises Ltd. ($3.07 billion), International Paper ($3.00 billion), Coinbase Global, Inc. ($2.93 billion), Cencora, Inc. ($2.54 billion), Paychex, Inc. ($2.53 billion), SoFi Technologies, Inc. ($2.24 billion), and Reddit, Inc. ($2.00 billion). View all of the most shorted stocks. What does it mean to sell short Innate Pharma stock? Short selling IPHA is an investing strategy that aims to generate trading profit from Innate Pharma as its price is falling. IPHA shares are trading down $0.04 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Innate Pharma? A short squeeze for Innate Pharma occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of IPHA, which in turn drives the price of the stock up even further. How often is Innate Pharma's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including IPHA, twice per month. The most recent reporting period available is November, 30 2024. More Short Interest Resources from MarketBeat Related Companies CARGO Therapeutics Short Interest Rapport Therapeutics Short Interest Entrada Therapeutics Short Interest Exscientia Short Interest Stoke Therapeutics Short Interest Pharvaris Short Interest Arbutus Biopharma Short Interest Humacyte Short Interest ORIC Pharmaceuticals Short Interest Autolus Therapeutics Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:IPHA) was last updated on 12/25/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredWe recommended Palantir in 2021, now we’re recommending this...My research indicates there is only one investment that can meet AI's unprecedented demand for energy.Behind the Markets | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Innate Pharma S.A. Please log in to your account or sign up in order to add this asset to your watchlist. Share Innate Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.